Your browser doesn't support javascript.
loading
Industry Perspective on Therapeutic Peptide Drug-Drug Interaction Assessments During Drug Development: A European Federation of Pharmaceutical Industries and Associations White Paper.
Säll, Carolina; Argikar, Upendra; Fonseca, Kari; Hilgendorf, Constanze; Lopes, Filipe; Riedel, Jens; Schiller, Hilmar; Sonesson, Anders; Umehara, Kenichi; Wang, Kai.
Affiliation
  • Säll C; Development Absorption, Distribution, Metabolism, and Excretion, Novo Nordisk A/S, Måløv, Denmark.
  • Argikar U; Non-clinical Development, Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA.
  • Fonseca K; Medicine Design, Worldwide Research, Development and Medical, Pfizer Inc., Cambridge, Massachusetts, USA.
  • Hilgendorf C; Drug Metabolism and Pharmacokinetics, Early Research and Development Cardiovascular Renal and Metabolism, Biopharmaceuticals R&D, AstraZeneca Gothenburg, Mölndal, Sweden.
  • Lopes F; Early Development Absorption, Distribution, Metabolism, and Excretion, Pharvaris GmbH, Zug, Switzerland.
  • Riedel J; Drug Metabolism and Pharmacokinetics, Sanofi-Aventis Deutschland GmbH, Frankfurt/Main, Germany.
  • Schiller H; Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Sonesson A; Global Drug Metabolism and Pharmacokinetics, Ferring Pharmaceuticals A/S, Kastrup, Denmark.
  • Umehara K; Pharmaceutical Sciences, Roche Pharma Research & Early Development, Roche Innovation Center, Basel, Switzerland.
  • Wang K; Drug Metabolism and Pharmacokinetics, Janssen Research & Development, San Diego, California, USA.
Clin Pharmacol Ther ; 113(6): 1199-1216, 2023 06.
Article de En | MEDLINE | ID: mdl-36633114

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Peptides / Cytochrome P-450 enzyme system Type d'étude: Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limites: Humans Langue: En Journal: Clin Pharmacol Ther Année: 2023 Type de document: Article Pays d'affiliation: Danemark Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Peptides / Cytochrome P-450 enzyme system Type d'étude: Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limites: Humans Langue: En Journal: Clin Pharmacol Ther Année: 2023 Type de document: Article Pays d'affiliation: Danemark Pays de publication: États-Unis d'Amérique